1629 related articles for article (PubMed ID: 24444048)
1. Established and novel disease-modifying treatments in multiple sclerosis.
Cross AH; Naismith RT
J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
3. Update on disease-modifying therapies for multiple sclerosis.
Vargas DL; Tyor WR
J Investig Med; 2017 Jun; 65(5):883-891. PubMed ID: 28130412
[TBL] [Abstract][Full Text] [Related]
4. Disease-modifying agents in multiple sclerosis.
O'Connor PW; Oh J
Handb Clin Neurol; 2014; 122():465-501. PubMed ID: 24507532
[TBL] [Abstract][Full Text] [Related]
5. Novel Agents for Relapsing Forms of Multiple Sclerosis.
Straus Farber R; Harel A; Lublin F
Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285
[TBL] [Abstract][Full Text] [Related]
6. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
Sørensen PS
J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis research: diagnostics, disease-modifying treatments, and emerging therapies.
Costello K
J Neurosci Nurs; 2013 Dec; 45(6 Suppl 1):S14-23. PubMed ID: 24217187
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of relapsing-remitting multiple sclerosis.
Tanasescu R; Ionete C; Chou IJ; Constantinescu CS
Biomed J; 2014; 37(2):41-9. PubMed ID: 24732658
[TBL] [Abstract][Full Text] [Related]
9. [Current immunotherapy of multiple sclerosis].
Paul F; Ruprecht K
Nervenarzt; 2015 Aug; 86(8):1031-42; quiz 1043-4. PubMed ID: 26253589
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of multiple sclerosis].
Csépány T
Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
[TBL] [Abstract][Full Text] [Related]
11. Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
Bonafede MM; Johnson BH; Wenten M; Watson C
Clin Ther; 2013 Oct; 35(10):1501-12. PubMed ID: 24139422
[TBL] [Abstract][Full Text] [Related]
12. Current and future disease-modifying therapies in multiple sclerosis.
Lim SY; Constantinescu CS
Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
[TBL] [Abstract][Full Text] [Related]
13. New management algorithms in multiple sclerosis.
Sorensen PS
Curr Opin Neurol; 2014 Jun; 27(3):246-59. PubMed ID: 24759080
[TBL] [Abstract][Full Text] [Related]
14. [Disease modifying therapies in multiple sclerosis].
Fukaura H
Nihon Rinsho; 2014 Nov; 72(11):2015-22. PubMed ID: 25518387
[TBL] [Abstract][Full Text] [Related]
15. An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Weinstock-Guttman B
Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis - established and novel therapeutic approaches.
Ehling R; Berger T; Reindl M
Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):3-15. PubMed ID: 20236038
[TBL] [Abstract][Full Text] [Related]
17. New and emerging disease modifying therapies for multiple sclerosis.
Saidha S; Eckstein C; Calabresi PA
Ann N Y Acad Sci; 2012 Jan; 1247():117-37. PubMed ID: 22224673
[TBL] [Abstract][Full Text] [Related]
18. Current disease-modifying treatment of multiple sclerosis.
Derwenskus J
Mt Sinai J Med; 2011; 78(2):161-75. PubMed ID: 21425262
[TBL] [Abstract][Full Text] [Related]
19. Emerging oral drugs for relapsing-remitting multiple sclerosis.
Gasperini C; Ruggieri S
Expert Opin Emerg Drugs; 2011 Dec; 16(4):697-712. PubMed ID: 22148963
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive treatments in multiple sclerosis.
Okuda DT
Handb Clin Neurol; 2014; 122():503-11. PubMed ID: 24507533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
